Evidence map›Paper›PMID 20085641›Full record

ArticleBMC medical research methodology2010

Design, recruitment, and retention of African-American smokers in a pharmacokinetic study.

Babalola Faseru, Lisa S Cox, Carrie A Bronars, Isaac Opole, Gregory A Reed, Matthew S Mayo, Jasjit S Ahluwalia, Kolawole S Okuyemi

Abstract read
In one paragraph

Article in BMC medical research methodology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Effects of menthol on the pharmacokinetics of bupropion among Black smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2012
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Babalola FaseruDepartment of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS, USA. bfaseru@kumc.edu
Lisa S Cox
Carrie A Bronars
Isaac Opole
Gregory A Reed
Matthew S Mayo
Jasjit S Ahluwalia
Kolawole S Okuyemi

Funding

Helping African American Light Smokers QuitR01CA091912 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI COX, LISA SANDERSON · 2001 to 2010
$5.6M
Effects of Menthol on Bupropion PharmacokineticsR21DA018720 · NIDA · UNIVERSITY OF MINNESOTA · PI OKUYEMI, KOLAWOLE S · 2005 to 2006
$403k
MOTION STUDY ANALYSIS WITH A SELSPOT II SYSTEMS10RR002394 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI PECKHAM, P. HUNTER · 1985 to 1985
–
NCI NIH HHS R01 CA091912NCRR NIH HHS M01 RR0239410NIDA NIH HHS R21 DA 018720NIDA NIH HHS R21 DA018720
6 · The paper itself

Abstract

backgroundAfrican-Americans remain underrepresented in clinical research despite experiencing a higher burden of disease compared to all other ethnic groups in the United States. The purpose of this article is to describe the study design and discuss strategies used to recruit and retain African-American smokers in a pharmacokinetic study.

methodsThe parent study was designed to evaluate the differences in the steady-state concentrations of bupropion and its three principal metabolites between African-American menthol and non-menthol cigarette smokers. Study participation consisted of four visits at a General Clinical Research Center (GCRC) over six weeks. After meeting telephone eligibility requirements, phone-eligible participants underwent additional screening during the first two GCRC visits. The last two visits (pharmacokinetic study phase) required repeated blood draws using an intravenous catheter over the course of 12 hours.

resultsFive hundred and fifteen African-American smokers completed telephone screening; 187 were phone-eligible and 92 were scheduled for the first GCRC visit. Of the 81 who attended the first visit, 48 individuals were enrolled in the pharmacokinetic study, and a total of 40 individuals completed the study (83% retention rate).

conclusionsAlthough recruitment of African-American smokers into a non-treatment, pharmacokinetic study poses challenges, retention is feasible. The results provide valuable information for investigators embarking on non-treatment laboratory-based studies among minority populations.

Indexed as

Black or African AmericanPatient SelectionBupropionFemaleHumansMaleMentholMethodsNontherapeutic Human ExperimentationPatient Acceptance of Health CareResearch DesignSmokingBupropionMenthol

Identifiers

PMID20085641
PMCPMC2850393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.